More gene therapy drug developers than ever are realizing the potential of gene therapies to treat a range of metabolic diseases, including lysosomal storage disorders. To pioneer these therapies, drug developers need access to solutions including:
- Identifying patients for clinical trials
- Establishing and using natural history studies
- Undertaking clinical trials with experience in rare disease and gene therapy
- Developing effective diagnostics to confirm diagnosis and trial eligibility
Partnering with us provides a unique platform to establish yourself as the go-to company for anyone developing metabolic gene therapies.
We have a limited number of partnership opportunities available, including virtual speaking positions across our agenda. The meeting will unite 80+ pre-clinical, translational & clinical specialists to engage with, so if you’re looking to showcase your expertise, demonstrate thought leadership, or generate leads to build new relationships with the industry, we can help build a bespoke partnership to support your business development objectives.
Email us at email@example.com for more information about the digital partnership opportunities available which will deliver on your 2021 commercial aims. Act now to stay ahead of the curve and seize the wealth of opportunity on offer.
Showcase your expertise to leading organisations by securing a virtual exhibition booth
Secure a spot on our expert speaker faculty to demonstrate thought leadership and drive brand exposure
Maximise the balance of 2:1 live content and targeted online networking to generate leads and build new relationships with gene therapy pioneers
Embrace the tech to meet your 2021 commercial objectives and educate decision-makers on how your expertise can deliver gene therapies to patients more effectively